These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9787892

  • 21. Neuroendocrine aspects of primary endogenous depression: IX. Receiver operating characteristic analysis of the dexamethasone suppression index vs. the dexamethasone suppression test in patients and controls.
    McCracken JT, Rubin RT, Poland RE.
    Psychiatry Res; 1990 Jan; 31(1):49-56. PubMed ID: 2315422
    [Abstract] [Full Text] [Related]

  • 22. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF, Hunt G, Kerr K, Caterson I.
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [Abstract] [Full Text] [Related]

  • 23. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
    Thompson LM, Rubin RT, McCracken JT.
    Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
    [Abstract] [Full Text] [Related]

  • 24. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
    Wiedemann K, Holsboer F.
    Biol Psychiatry; 1987 Nov; 22(11):1340-8. PubMed ID: 3663786
    [Abstract] [Full Text] [Related]

  • 25. The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.
    Holsboer F, Wiedemann K, Gerken A, Boll E.
    Psychiatry Res; 1986 Feb; 17(2):97-103. PubMed ID: 3961034
    [Abstract] [Full Text] [Related]

  • 26. Serum dexamethasone concentrations in endogenous depressives before, during, and after treatment: preliminary observations.
    Poland RE, Rubin RT, Lesser IM.
    Biol Psychiatry; 1988 Apr 01; 23(7):705-10. PubMed ID: 3370267
    [Abstract] [Full Text] [Related]

  • 27. The dexamethasone suppression test: importance of dexamethasone concentrations.
    Maguire KP, Schweitzer I, Biddle N, Bridge S, Tiller JW.
    Biol Psychiatry; 1987 Aug 01; 22(8):957-67. PubMed ID: 3607137
    [Abstract] [Full Text] [Related]

  • 28. Neuroendocrine aspects of primary endogenous depression: VI. Receiver operating characteristic analysis of the cortisol suppression index versus the dexamethasone suppression test in patients and matched controls.
    McCracken JT, Rubin RT, Poland RE.
    Psychiatry Res; 1988 Oct 01; 26(1):69-78. PubMed ID: 3237907
    [Abstract] [Full Text] [Related]

  • 29. State specificity of DST abnormalities in geriatric depression.
    Meyers BS, Alpert S, Gabriele M, Kakuma T, Kalayam B, Alexopoulos GS.
    Biol Psychiatry; 1988 Oct 01; 34(1-2):108-14. PubMed ID: 8373930
    [Abstract] [Full Text] [Related]

  • 30. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 01; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 31. Plasma dexamethasone and cortisol levels in depressed outpatients.
    Asnis GM, Friedman JM, Miller AH, Iqbal N, Lo ES, Cooper TB, Halbreich U, Lemus CZ, van Praag HM, Rubinson E.
    J Affect Disord; 1989 Jul 01; 16(1):5-10. PubMed ID: 2521652
    [Abstract] [Full Text] [Related]

  • 32. Pituitary and adrenal hormone responsiveness to Synacthen in melancholic subjects versus subjects with minor depression.
    Maes M, Meltzer H, Cosyns P, Calabrese J, D'Hondt P, Blockx P, Vandervorst C, Raus J.
    Biol Psychiatry; 1989 Jul 01; 33(8-9):624-9. PubMed ID: 8392386
    [Abstract] [Full Text] [Related]

  • 33. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F, Gerken A, Steiger A, Fass V.
    Acta Psychiatr Scand; 1984 May 01; 69(5):383-90. PubMed ID: 6730994
    [Abstract] [Full Text] [Related]

  • 34. Age and cortisol suppression by dexamethasone in normal subjects.
    Weiner MF.
    J Psychiatr Res; 1989 May 01; 23(2):163-8. PubMed ID: 2585347
    [Abstract] [Full Text] [Related]

  • 35. The effect of stress on the dexamethasone suppression test.
    Ceulemans DL, Westenberg HG, van Praag HM.
    Psychiatry Res; 1985 Mar 01; 14(3):189-95. PubMed ID: 3858891
    [Abstract] [Full Text] [Related]

  • 36. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors.
    Cassidy F, Ritchie JC, Verghese K, Carroll BJ.
    Biol Psychiatry; 2000 Apr 01; 47(7):677-80. PubMed ID: 10745062
    [Abstract] [Full Text] [Related]

  • 37. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G, Schlesser MA, Rush AJ, Orsulak P, Weissenburger J.
    J Clin Psychiatry; 1984 Oct 01; 45(10):431-2. PubMed ID: 6480568
    [Abstract] [Full Text] [Related]

  • 38. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
    Neuropsychobiology; 1998 Oct 01; 37(3):142-5. PubMed ID: 9597670
    [Abstract] [Full Text] [Related]

  • 39. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug 01; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 40. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM, Davis KL, Davis BM, Krieger DT.
    Psychiatry Res; 1983 Feb 01; 8(2):105-9. PubMed ID: 6574528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.